Abramson Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Abramson Cancer Center (Abramson) formerly Penn Medicines Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include integrative medicine and wellness, nutritional counseling, pastoral care, patient education and psychological counselling. It offers cancer treatments such as bone marrow and stem cell transplantation, chemotherapy, clinical trials, hormone therapy, immunotherapy, integrative medicine and wellness, managing treatment side effects, photodynamic therapy, proton therapy, radiation treatment, surgery, targeted therapy,vaccine therapy. Abramson treats for bladder cancer, breast cancer, kidney cancer, lung cancer, ovarian cancer, thyroid cancer, among others. The centre pathologists perform specialized techniques including immunohistochemical analyses, electron microscopy and molecular studies. Its centre offers services in various hospital locations across the US. Abramson Cancer Center is headquartered in Philadelphia, Pennsylvania, the US.

Abramson Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abramson Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Incyte Enters into Research Agreement with Abramson Cancer Center 10
Celgene Enters into Co-Development Agreement with Abramson Cancer Center 11
Epic Sciences Partners with Abramson Cancer Center 12
Abramson Cancer Center - Key Competitors 13
Abramson Cancer Center - Key Employees 14
Abramson Cancer Center - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Oct 03, 2018: Patient death following CAR-T therapy highlights serious manufacturing issues 16
Sep 07, 2018: Penn Medicine Researchers Receive Big Data Grant from NIH to Test New Approach for Personalized Breast Cancer Treatments 18
Nov 01, 2017: CVS Health Foundation Awards $1 Million Dollars in Grants to Eight Cancer Centers to Increase Smoking Cessation Resources in the Oncology Setting 19
May 04, 2017: New $21 Million Gift Puts Basser Center for BRCA at the Forefront of Advancements for Patients at Risk of Inherited Cancers 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List Of Tables


Abramson Cancer Center, Pharmaceuticals & Healthcare, Key Facts 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abramson Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abramson Cancer Center, Deals By Therapy Area, 2012 to YTD 2018 8
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Incyte Enters into Research Agreement with Abramson Cancer Center 10
Celgene Enters into Co-Development Agreement with Abramson Cancer Center 11
Epic Sciences Partners with Abramson Cancer Center 12
Abramson Cancer Center, Key Competitors 13
Abramson Cancer Center, Key Employees 14
Abramson Cancer Center, Other Locations 15

List Of Figures


Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Abramson Cancer Center - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Abramson Cancer Center (Abramson) formerly Penn Medicines Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment

USD 250 View Report

Abramson Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Abramson Cancer Center, formerly Penn Medicines Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of

USD 250 View Report

University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review

University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a

USD 125 View Report

H. Lee Moffitt Cancer Center and Research Institute Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider. It is engaged in the development of early stage translational research aimed at the rapid

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available